Serveur d'exploration Chloroquine - Curation (Ncbi)

Index « Keywords » - entrée « Chloroquine (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Chloroquine (administration & dosage) < Chloroquine (adverse effects) < Chloroquine (analogs & derivatives)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000001 (1999) M. Baltzan [Canada] ; S. Mehta ; T H Kirkham ; M G CosioRandomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis.
000056 (1992) M M El-Mofty [Égypte] ; V V Khudoley ; S A Sakr ; H S Abdel-GawadThe carcinogenicity of some antimalarial drugs using the Egyptian toad Bufo regularis as a biological test animal.
000062 (2004) Jeffrey H. Freihage [États-Unis] ; Nehu C. Patel ; William R. Jacobs ; Maria Picken ; Raoul Fresco ; Krystyna Malinowska ; Barbara A. Pisani ; Jose C. Mendez ; Robert C. Lichtenberg ; Bryan K. Foy ; Mamdouh Bakhos ; G Martin MullenHeart transplantation in a patient with chloroquine-induced cardiomyopathy.
000068 (1977) K U Seiler ; H J Thiel ; O. Wassermann[Chloroquine keratopathy as an example of drug-induced phospholipidosis (contribution to the pathogenesis of cornea verticillata) (author's transl)].
000102 (1975) C E Orfanos ; U. RunneTumor- and drug-induced cutaneous neuro-phospholipidosis.
000117 (????) A O Okanlawon [Nigeria] ; A B Ejiwunmi ; M O Dada ; O A AshiruThe effects of chloroquine on pulmonary saccular growth near term.
000140 (2010) Keith C. Meyer [États-Unis] ; Catherine Decker ; Robert BaughmanToxicity and monitoring of immunosuppressive therapy used in systemic autoimmune diseases.
001049 (1988) U M Joshi ; P R Kodavanti ; B. Coudert ; T M Dwyer ; H M MehendaleTypes of interaction of amphiphilic drugs with phospholipid vesicles.
001066 (1973) H. Lüllmann ; R. Lüllmann-Rauch ; O. Wassermann[Drug-induced phospholipid storage disease].
001068 (1968) Chloroquine in pulmonary sarcoidosis.
001084 (1967) Chloroquine in the treatment of sarcoidosis. A report from the Research Committee of the British Tuberculosis Association.
001115 (1964) L E Siltzbach ; A S TeirsteinChloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis.
001146 (1993) A O Okanlawon [Nigeria] ; A B Ejiwunmi ; M O Dada ; O A AshiruChloroquine-induced retardation of foetal lung maturation in rats.
001160 (1993) A O Okanlawon [Nigeria] ; A B Ejiwunmi ; M O Dada ; O A AshiruMorphometric analysis of the effect of chloroquine on rat foetal lung maturation.
001176 (1997) U. Jedynak ; M. Ciezarek ; P. Kopi SkiPulmonary infiltrates with masto- and lymphocytosis in BALF associated with arechine.
001185 (1998) O P Sharma [États-Unis]Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Chloroquine (adverse effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Chloroquine (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Chloroquine (adverse effects)
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021